The Ministry of Chemicals and Fertilisers has invited applications from eligible entities under the Scheme for Strengthening of Medical Device Industry (SMDI), offering financial benefits of up to Rs 10 crore to promote domestic manufacturing and reduce import dependence.
Two Sub-Schemes to Boost Manufacturing and Clinical Studies
The government has opened applications under two key sub-schemes: the Marginal Investment Scheme for Reducing Import Dependence and the Medical Device Clinical Studies Support Scheme (MDCSS). Under the Marginal Investment Scheme, selected applicants will receive a one-time capital subsidy of up to Rs 10 crore on a reimbursement basis for manufacturing key components, raw materials, finished devices or accessories aimed at reducing import dependence.
According to the official release, selected applicants would be incentivised through a one-time capital subsidy of up to Rs 10 crore on a reimbursement basis. The scheme targets components, raw materials, finished devices or accessories to reduce import dependence.
Financial Support for Clinical Studies
Under the MDCSS, the government will provide financial assistance of up to Rs 5 crore to eligible applicants for conducting clinical investigations, clinical performance evaluations, post-market follow-up studies and animal studies, also on a reimbursement basis. The release stated that the department will provide financial support of up to Rs 5 crore under the MDCSS scheme for conducting these studies.
Application Deadline and Guidelines
Eligible applicants are required to submit proposals online through the official portal http://smdi.lsssdc.in on or before July 23, 2026 at 6:00 PM. Detailed guidelines, eligibility criteria and application procedures are available on the Department of Pharmaceuticals website at https://pharma-dept.gov.in/schemes.
